|
Variable
|
Control patients (n = 30)
|
SCT patients (n = 28)
|
p value
|
|---|
|
Age (years)
|
57 (37–69)
|
54 (35–67)
|
0.15
|
|
Gender (M/F)
|
19/11
|
14/14
|
0.31
|
|
HVPG (mmHg)
|
19.9 ± 2.4
|
19.1 ± 2.8
|
0.28
|
|
MELD score
|
19.1 ± 4.0
|
19.0 ± 3.8
|
0.86
|
|
Cirrhosis (%)
|
100
|
100
|
0.99
|
|
ASH (n, %)
|
25 (83.3%)
|
22 (78.6%)
|
0.64
|
|
Corticosteroid treatment (n, %)
|
22 (73.3%)
|
16 (57.1%)
|
0.59
|
-
ASH alcoholic steatohepatitis (full histological definition), F female, HVPG hepatic venous pressure gradient, M male, MELD model for end stage liver disease, SCT stem cell therapy
